RecruitingPhase 2NCT05004610
Hypertonic Lactate After Cardiac Arrest
Sponsor
Erasme University Hospital
Enrollment
125 participants
Start Date
Feb 19, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age > 18 years old
- Sustained (> 20 minutes) return of spontaneous circulation (ROSC)
- Comatose (GCS < 9)
- Time to ROSC > 15'
Exclusion Criteria4
- Protected categories (Pregnant women)
- Anticipated withdrawal of support within 24 hours
- Traumatic cause of cardiac arrest
- Body weight at admission > 120Kg
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGSodium Lactate Solution
continuous intravenous infusion of molar sodium lactate
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05004610
Related Trials
Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock.
NCT0581785114 locations
Compression Only CPR Versus Standard CPR in Out-Of-Hospital Cardiac Arrest - A Randomized Survival Study
NCT039811072 locations
OSA as a Remote Ischemic Preconditioning in Vascular Surgery
NCT046305351 location
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
NCT040054691 location
In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta
NCT074347261 location